According to this study, over the next five years the Albumin (as Excipient) market will register a 6.3%% CAGR in terms of revenue, the global market size will reach $ 5262.5 million by 2025, from $ 4120.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albumin (as Excipient) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Albumin (as Excipient), covering the supply chain analysis, impact assessment to the Albumin (as Excipient) market size growth rate in several scenarios, and the measures to be undertaken by Albumin (as Excipient) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL
Albumedix
Grifols
Octapharma
Hualan Bio
Takeda
Kedrion
CBPO
LFB Group
Shanghai RAAS
Biotest
HiMedia
Ventria (InVitria)
Merck
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Albumin (as Excipient) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Albumin (as Excipient) market by identifying its various subsegments.
Focuses on the key global Albumin (as Excipient) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Albumin (as Excipient) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Albumin (as Excipient) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Albumin (as Excipient) Consumption 2015-2025
2.1.2 Albumin (as Excipient) Consumption CAGR by Region
2.2 Albumin (as Excipient) Segment by Type
2.2.1 Human Serum Albumin
2.2.2 Recombinant Albumin
2.3 Albumin (as Excipient) Consumption by Type
2.3.1 Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Albumin (as Excipient) Sale Price by Type (2015-2020)
2.4 Albumin (as Excipient) Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Therapeutics
2.5 Albumin (as Excipient) Consumption by Application
2.5.1 Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
2.5.2 Global Albumin (as Excipient) Value and Market Share by Type (2015-2020)
2.5.3 Global Albumin (as Excipient) Sale Price by Type (2015-2020)
3 Global Albumin (as Excipient) by Company
3.1 Global Albumin (as Excipient) Sales Market Share by Company
3.1.1 Global Albumin (as Excipient) Sales by Company (2018-2020)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2018-2020)
3.2 Global Albumin (as Excipient) Revenue Market Share by Company
3.2.1 Global Albumin (as Excipient) Revenue by Company (2018-2020)
3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2018-2020)
3.3 Global Albumin (as Excipient) Sale Price by Company
3.4 Global Albumin (as Excipient) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Albumin (as Excipient) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Albumin (as Excipient) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Albumin (as Excipient) by Regions
4.1 Albumin (as Excipient) by Regions
4.2 Americas Albumin (as Excipient) Consumption Growth
4.3 APAC Albumin (as Excipient) Consumption Growth
4.4 Europe Albumin (as Excipient) Consumption Growth
4.5 Middle East & Africa Albumin (as Excipient) Consumption Growth
5 Americas
5.1 Americas Albumin (as Excipient) Consumption by Countries
5.1.1 Americas Albumin (as Excipient) Consumption by Countries (2015-2020)
5.1.2 Americas Albumin (as Excipient) Value by Countries (2015-2020)
5.2 Americas Albumin (as Excipient) Consumption by Type
5.3 Americas Albumin (as Excipient) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Albumin (as Excipient) Consumption by Regions
6.1.1 APAC Albumin (as Excipient) Consumption by Regions (2015-2020)
6.1.2 APAC Albumin (as Excipient) Value by Regions (2015-2020)
6.2 APAC Albumin (as Excipient) Consumption by Type
6.3 APAC Albumin (as Excipient) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Albumin (as Excipient) by Countries
7.1.1 Europe Albumin (as Excipient) Consumption by Countries (2015-2020)
7.1.2 Europe Albumin (as Excipient) Value by Countries (2015-2020)
7.2 Europe Albumin (as Excipient) Consumption by Type
7.3 Europe Albumin (as Excipient) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Albumin (as Excipient) by Countries
8.1.1 Middle East & Africa Albumin (as Excipient) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Albumin (as Excipient) Value by Countries (2015-2020)
8.2 Middle East & Africa Albumin (as Excipient) Consumption by Type
8.3 Middle East & Africa Albumin (as Excipient) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Albumin (as Excipient) Distributors
10.3 Albumin (as Excipient) Customer
11 Global Albumin (as Excipient) Market Forecast
11.1 Global Albumin (as Excipient) Consumption Forecast (2021-2025)
11.2 Global Albumin (as Excipient) Forecast by Regions
11.2.1 Global Albumin (as Excipient) Forecast by Regions (2021-2025)
11.2.2 Global Albumin (as Excipient) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Albumin (as Excipient) Forecast by Type
11.8 Global Albumin (as Excipient) Forecast by Application
12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Albumin (as Excipient) Product Offered
12.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 Albumedix
12.2.1 Company Information
12.2.2 Albumin (as Excipient) Product Offered
12.2.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Albumedix Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Albumin (as Excipient) Product Offered
12.3.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 Albumin (as Excipient) Product Offered
12.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Hualan Bio
12.5.1 Company Information
12.5.2 Albumin (as Excipient) Product Offered
12.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Hualan Bio Latest Developments
12.6 Takeda
12.6.1 Company Information
12.6.2 Albumin (as Excipient) Product Offered
12.6.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Takeda Latest Developments
12.7 Kedrion
12.7.1 Company Information
12.7.2 Albumin (as Excipient) Product Offered
12.7.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Kedrion Latest Developments
12.8 CBPO
12.8.1 Company Information
12.8.2 Albumin (as Excipient) Product Offered
12.8.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 CBPO Latest Developments
12.9 LFB Group
12.9.1 Company Information
12.9.2 Albumin (as Excipient) Product Offered
12.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 LFB Group Latest Developments
12.10 Shanghai RAAS
12.10.1 Company Information
12.10.2 Albumin (as Excipient) Product Offered
12.10.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Shanghai RAAS Latest Developments
12.11 Biotest
12.11.1 Company Information
12.11.2 Albumin (as Excipient) Product Offered
12.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Biotest Latest Developments
12.12 HiMedia
12.12.1 Company Information
12.12.2 Albumin (as Excipient) Product Offered
12.12.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 HiMedia Latest Developments
12.13 Ventria (InVitria)
12.13.1 Company Information
12.13.2 Albumin (as Excipient) Product Offered
12.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Ventria (InVitria) Latest Developments
12.14 Merck
12.14.1 Company Information
12.14.2 Albumin (as Excipient) Product Offered
12.14.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Merck Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Albumin (as Excipient) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Human Serum Albumin
Table 5. Major Players of Recombinant Albumin
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Table 8. Global Albumin (as Excipient) Revenue by Type (2015-2020) ($ million)
Table 9. Global Albumin (as Excipient) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Albumin (as Excipient) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Table 13. Global Albumin (as Excipient) Value by Application (2015-2020)
Table 14. Global Albumin (as Excipient) Value Market Share by Application (2015-2020)
Table 15. Global Albumin (as Excipient) Sale Price by Application (2015-2020)
Table 16. Global Albumin (as Excipient) Sales by Company (2017-2019) (MT)
Table 17. Global Albumin (as Excipient) Sales Market Share by Company (2017-2019)
Table 18. Global Albumin (as Excipient) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Albumin (as Excipient) Revenue Market Share by Company (2017-2019)
Table 20. Global Albumin (as Excipient) Sale Price by Company (2017-2019)
Table 21. Global Albumin (as Excipient) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Albumin (as Excipient) Products Offered
Table 23. Albumin (as Excipient) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Albumin (as Excipient) Consumption by Regions 2015-2020 (MT)
Table 25. Global Albumin (as Excipient) Consumption Market Share by Regions 2015-2020
Table 26. Global Albumin (as Excipient) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Albumin (as Excipient) Value Market Share by Regions 2015-2020
Table 28. Americas Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)
Table 29. Americas Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Albumin (as Excipient) Value Market Share by Countries (2015-2020)
Table 32. Americas Albumin (as Excipient) Consumption by Type (2015-2020) (MT)
Table 33. Americas Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Table 34. Americas Albumin (as Excipient) Consumption by Application (2015-2020) (MT)
Table 35. Americas Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Table 36. APAC Albumin (as Excipient) Consumption by Regions (2015-2020) (MT)
Table 37. APAC Albumin (as Excipient) Consumption Market Share by Regions (2015-2020)
Table 38. APAC Albumin (as Excipient) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Albumin (as Excipient) Value Market Share by Regions (2015-2020)
Table 40. APAC Albumin (as Excipient) Consumption by Type (2015-2020) (MT)
Table 41. APAC Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Table 42. APAC Albumin (as Excipient) Consumption by Application (2015-2020) (MT)
Table 43. APAC Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Table 44. Europe Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)
Table 45. Europe Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Albumin (as Excipient) Value Market Share by Countries (2015-2020)
Table 48. Europe Albumin (as Excipient) Consumption by Type (2015-2020) (MT)
Table 49. Europe Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Table 50. Europe Albumin (as Excipient) Consumption by Application (2015-2020) (MT)
Table 51. Europe Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Albumin (as Excipient) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Albumin (as Excipient) Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Albumin (as Excipient) Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Table 60. Albumin (as Excipient) Distributors List
Table 61. Albumin (as Excipient) Customer List
Table 62. Global Albumin (as Excipient) Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Albumin (as Excipient) Consumption Market Forecast by Regions
Table 64. Global Albumin (as Excipient) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Albumin (as Excipient) Value Market Share Forecast by Regions
Table 66. Global Albumin (as Excipient) Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Albumin (as Excipient) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Albumin (as Excipient) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Albumin (as Excipient) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Albumin (as Excipient) Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Albumin (as Excipient) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Albumin (as Excipient) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Albumin (as Excipient) Value Market Share Forecast by Application (2021-2025)
Table 74. CSL Product Offered
Table 75. CSL Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. CSL Main Business
Table 77. CSL Latest Developments
Table 78. CSL Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 79. Albumedix Product Offered
Table 80. Albumedix Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Albumedix Main Business
Table 82. Albumedix Latest Developments
Table 83. Albumedix Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Product Offered
Table 85. Grifols Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. Grifols Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 89. Octapharma Product Offered
Table 90. Octapharma Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Octapharma Main Business
Table 92. Octapharma Latest Developments
Table 93. Octapharma Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 94. Hualan Bio Product Offered
Table 95. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Hualan Bio Main Business
Table 97. Hualan Bio Latest Developments
Table 98. Hualan Bio Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 99. Takeda Product Offered
Table 100. Takeda Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Takeda Main Business
Table 102. Takeda Latest Developments
Table 103. Takeda Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Product Offered
Table 105. Kedrion Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Kedrion Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. CBPO Product Offered
Table 110. CBPO Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. CBPO Main Business
Table 112. CBPO Latest Developments
Table 113. CBPO Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 114. LFB Group Product Offered
Table 115. LFB Group Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 116. LFB Group Main Business
Table 117. LFB Group Latest Developments
Table 118. LFB Group Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Product Offered
Table 120. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 124. Biotest Product Offered
Table 125. Biotest Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 126. Biotest Main Business
Table 127. Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Biotest Latest Developments
Table 129. HiMedia Product Offered
Table 130. HiMedia Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 131. HiMedia Main Business
Table 132. HiMedia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. HiMedia Latest Developments
Table 134. Ventria (InVitria) Product Offered
Table 135. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 136. Ventria (InVitria) Main Business
Table 137. Ventria (InVitria) Latest Developments
Table 138. Ventria (InVitria) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Merck Product Offered
Table 140. Merck Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 141. Merck Main Business
Table 142. Merck Latest Developments
Table 143. Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Albumin (as Excipient)
Figure 2. Albumin (as Excipient) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Albumin (as Excipient) Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Albumin (as Excipient) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Human Serum Albumin
Figure 7. Product Picture of Recombinant Albumin
Figure 8. Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)
Figure 9. Global Albumin (as Excipient) Value Market Share by Type (2015-2020)
Figure 10. Albumin (as Excipient) Consumed in Cell Culture Media
Figure 11. Global Albumin (as Excipient) Market: Cell Culture Media (2015-2020) (MT)
Figure 12. Global Albumin (as Excipient) Market: Cell Culture Media (2015-2020) ($ Millions)
Figure 13. Albumin (as Excipient) Consumed in Medical Supplements
Figure 14. Global Albumin (as Excipient) Market: Medical Supplements (2015-2020) (MT)
Figure 15. Global Albumin (as Excipient) Market: Medical Supplements (2015-2020) ($ Millions)
Figure 16. Albumin (as Excipient) Consumed in Therapeutics
Figure 17. Global Albumin (as Excipient) Market: Therapeutics (2015-2020) (MT)
Figure 18. Global Albumin (as Excipient) Market: Therapeutics (2015-2020) ($ Millions)
Figure 19. Global Albumin (as Excipient) Consumption Market Share by Application (2015-2020)
Figure 20. Global Albumin (as Excipient) Value Market Share by Application (2015-2020)
Figure 21. Global Albumin (as Excipient) Sales Market Share by Company in 2017
Figure 22. Global Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 23. Global Albumin (as Excipient) Revenue Market Share by Company in 2017
Figure 24. Global Albumin (as Excipient) Revenue Market Share by Company in 2019
Figure 25. Global Albumin (as Excipient) Sale Price by Company in 2019
Figure 26. Global Albumin (as Excipient) Consumption Market Share by Regions 2015-2020
Figure 27. Global Albumin (as Excipient) Value Market Share by Regions 2015-2020
Figure 28. Americas Albumin (as Excipient) Consumption 2015-2020 (MT)
Figure 29. Americas Albumin (as Excipient) Value 2015-2020 ($ Millions)
Figure 30. APAC Albumin (as Excipient) Consumption 2015-2020 (MT)
Figure 31. APAC Albumin (as Excipient) Value 2015-2020 ($ Millions)
Figure 32. Europe Albumin (as Excipient) Consumption 2015-2020 (MT)
Figure 33. Europe Albumin (as Excipient) Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Albumin (as Excipient) Consumption 2015-2020 (MT)
Figure 35. Middle East & Africa Albumin (as Excipient) Value 2015-2020 ($ Millions)
Figure 36. Americas Albumin (as Excipient) Consumption Market Share by Countries in 2019
Figure 37. Americas Albumin (as Excipient) Value Market Share by Countries in 2019
Figure 38. Americas Albumin (as Excipient) Consumption Market Share by Type in 2019
Figure 39. Americas Albumin (as Excipient) Consumption Market Share by Application in 2019
Figure 40. United States Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 41. United States Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 43. Canada Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 45. Mexico Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Albumin (as Excipient) Consumption Market Share by Countries in 2019
Figure 47. APAC Albumin (as Excipient) Value Market Share by Regions in 2019
Figure 48. APAC Albumin (as Excipient) Consumption Market Share by Type in 2019
Figure 49. APAC Albumin (as Excipient) Consumption Market Share by Application in 2019
Figure 50. China Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 51. China Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 53. Japan Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 55. Korea Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 57. Southeast Asia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 58. India Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 59. India Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 61. Australia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Albumin (as Excipient) Consumption Market Share by Countries in 2019
Figure 63. Europe Albumin (as Excipient) Value Market Share by Countries in 2019
Figure 64. Europe Albumin (as Excipient) Consumption Market Share by Type in 2019
Figure 65. Europe Albumin (as Excipient) Consumption Market Share by Application in 2019
Figure 66. Germany Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 67. Germany Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 68. France Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 69. France Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 70. UK Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 71. UK Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 73. Italy Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 75. Russia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Albumin (as Excipient) Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Application in 2019
Figure 80. Egypt Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 81. Egypt Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 83. South Africa Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 85. Israel Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 87. Turkey Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Albumin (as Excipient) Consumption Growth 2015-2020 (MT)
Figure 89. GCC Countries Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)
Figure 90. Global Albumin (as Excipient) Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 91. Global Albumin (as Excipient) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 93. Americas Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 94. APAC Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 95. APAC Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 96. Europe Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 97. Europe Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 99. Middle East & Africa Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 100. United States Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 101. United States Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 102. Canada Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 103. Canada Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 104. Mexico Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 105. Mexico Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 106. Brazil Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 107. Brazil Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 108. China Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 109. China Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 110. Japan Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 111. Japan Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 112. Korea Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 113. Korea Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 115. Southeast Asia Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 116. India Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 117. India Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 118. Australia Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 119. Australia Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 120. Germany Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 121. Germany Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 122. France Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 123. France Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 124. UK Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 125. UK Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 126. Italy Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 127. Italy Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 128. Russia Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 129. Russia Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 130. Spain Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 131. Spain Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 132. Egypt Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 133. Egypt Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 134. South Africa Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 135. South Africa Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 136. Israel Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 137. Israel Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 138. Turkey Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 139. Turkey Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Albumin (as Excipient) Consumption 2021-2025 (MT)
Figure 141. GCC Countries Albumin (as Excipient) Value 2021-2025 ($ Millions)
Figure 142. CSL Albumin (as Excipient) Market Share (2018-2020)
Figure 143. Albumedix Albumin (as Excipient) Market Share (2018-2020)
Figure 144. Grifols Albumin (as Excipient) Market Share (2018-2020)
Figure 145. Octapharma Albumin (as Excipient) Market Share (2018-2020)
Figure 146. Hualan Bio Albumin (as Excipient) Market Share (2018-2020)
Figure 147. Takeda Albumin (as Excipient) Market Share (2018-2020)
Figure 148. Kedrion Albumin (as Excipient) Market Share (2018-2020)
Figure 149. CBPO Albumin (as Excipient) Market Share (2018-2020)
Figure 150. LFB Group Albumin (as Excipient) Market Share (2018-2020)
Figure 151. Shanghai RAAS Albumin (as Excipient) Market Share (2018-2020)
Figure 152. Biotest Albumin (as Excipient) Market Share (2018-2020)
Figure 153. HiMedia Albumin (as Excipient) Market Share (2018-2020)
Figure 154. Ventria (InVitria) Albumin (as Excipient) Market Share (2018-2020)
Figure 155. Merck Albumin (as Excipient) Market Share (2018-2020)